Quantcast

Industry news that matters to you.  Learn more

Biomarker Commons Named Personalized Medicine World Conference (PMWC) Media Partner

Reading time: 3 – 5 minutes

The 4th Personalized Medicine World Conference (PMWC) 2012 will be held in Mountain View, California from January 23rd-24th at Silicon Valley’s Computer History Museum. PMWC brings together the thought-leaders in business, government, healthcare-delivery, research and technology for one information-rich, two-day conference.

In addition, companies, ranging from emerging to public, have several exhibition and presentation options to promote their products and services. The conference provides an opportunity to interact with over 1,000 PMWC participants actively involved in leading the personalized medicine revolution.

Biomarker Commons has been selected be a media partner with the 2012 Personalized Medicine World Conference (PMWC), organized and produced by Silicom Ventures.

Launched by Silicon Valley entrepreneurs and investors in 2009, the Personalized Medicine World Conference (PMWC) is the only fully integrated conference to examine the advances and challenges of Personalized Medicine through a practical lens.

Conference tracks include:

  • Emerging Technologies
  • Into the clinic
  • Rx/Dx Opportunities
  • Regulatory Myths & Facts
  • Economics: Payer Perspective
  • NextGen Health IT
  • “PMWC 2012 Most Promising Company” competition

Confirmed speakers include:

  • Brian Druker M.D., Director of the Oregon Health & Science University (OHSU) Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, OHSU, and an Investigator of the Howard Hughes Medical Institute (PMWC 2012 Honorary Keynote Speaker)
  • Naomi Aronson, Ph.D. Executive Director, Technology Evaluation Center (TEC) Blue Cross Blue Shield Association
  • Barrett Bready President & Chief Executive Officer NABsys
  • Pierre Cassigneul President & Chief Executive Officer XDx Cardio
  • William Dalton Ph.D., M.D. President, CEO & Director Moffitt Cancer Center
  • Laura Esserman, M.D., MBA Director of Carol Franc Buck Breast Care Center & Professor of Surgery and Radiology UCSF
  • John Frels, Ph.D. Divisional Vice President Abbott Diagnostics
  • David Galas Senior Vice President Institute for Systems Biology
  • Kathy Giusti Founder & Chief Executive Officer Multiple Myeloma Foundation
  • James Heywood Co-Founder & Chairman PatientsLikeMe
  • Andrea Klemes, DO, FACE Medical Director MDVIP
  • Jon Kobashigawa, M.D. Associate Director Cedars-Sinai Heart Institute
  • Walter Koch, Ph.D. Vice President & Head of Global Research Roche Molecular Systems
  • Eric Lai, Ph.D. Senior Vice President, Research & Development Gen-Probe, Inc.
  • C. Ola Landgren, M.D. Senior Investigator National Cancer Institute, CCR, NIH
  • David H. Ledbetter, Ph.D., FACMG Executive Vice President & Chief Scientific Officer Geisinger Health System
  • Ronald Levy, M.D. Chief, Division of Oncology Stanford Medical School
  • Elizabeth Mansfield, Ph.D. Director of Personalized Medicine, Office of In Vitro Diagnostics, Center for Devices and Radiological Health FDA
  • David Parkinson, M.D. CEO Nodality
  • Scott Patterson, Ph.D. Executive Director Amgen Molecular Sciences
  • Michael Phelps, Ph.D. Director of Institute for Molecular Medicine at David Geffen School of Medicine UCLA
  • Catherine Polizzi, Ph.D. Partner Morrison & Foerster LLP
  • Reed Tuckson, M.D. Executive Vice President and Chief of Medical Affairs UnitedHealth Group (tentative)

The 4th Personalized Medicine World Conference (PMWC) 2012 will be held in Mountain View, California from January 23rd-24th at Silicon Valley’s Computer History Museum.

Biomarker Commons email subscribers receive a special discount on registration. It’s another great reason to subscribe to full text biomarker news alerts or fast scan (headline only) biomarker news alerts, only from Biomarker Commons.